Prevention & Management of PCOS Rashmi Kudesia, M.D. M.Sc. Icahn School of Medicine at Mount Sinai November 18, 2015.

Slides:



Advertisements
Similar presentations
Treating Type 2 Diabetes in Obese Patients with Bariatric / Metabolic Surgery Highlights of Evidence from Recent Studies NAME DATE ©2012 Ethicon Endo-Surgery,
Advertisements

C. Matthew Peterson, M.D. Park City, Utah 2015
Assessment of Overweight and Obesity and the Need for Weight Loss Dr. David L. Gee FCSN/PE 446 Nutrition, Weight Control & Exercise.
Definitions Body Mass Index (BMI) describes relative weight for height: weight (kg)/height (m 2 ) Overweight = 25–29.9 BMI Obesity = >30 BMI.
Obesity.
Cardio-Metabolic Syndrome Guidelines on Education, Detection and Early Treatment  Heval Mohamed Kelli, PGY-2 Emory Internal Medicine Residency no conflict.
SUPERSIZED NATION By Jennifer Ericksen August 24, 2007.
Bariatric Surgery vs. Intensive Medical Therapy in Obese Diabetic Patients: 3-Year Outcome Bariatric Surgery vs. Intensive Medical Therapy in Obese Diabetic.
Diabetes in Pregnancy Screening.
OBESITY and CHD Nathan Wong. OBESITY AHA and NIH have recognized obesity as a major modifiable risk factor for CHD Obesity is a risk factor for development.
Polycystic Ovarian Syndrome
Reducing Your Risk of Cardiovascular Disease
Presentation Package for Concepts of Physical Fitness 14e
DR. TARIK Y. ZAMZAMI MD, CABOG, FICS ASSOCIATE PROFESSOR CONSULTANT OB/GYN
Copyright © 2008 Delmar. All rights reserved. Chapter 21 Populations with Chronic Diseases.
ADVICE. Advice Strongly advise adherence to diet and medication Smoking cessation, exercise, weight reduction Ensure diabetes education and advise Diabetes.
Facts and Fiction about Type 2 Diabetes Michael L. Parchman, MD Department of Family & Community Medicine September 2004.
Only You Can Prevent CVD Matthew Johnson, MD. What can we do to prevent CVD?
Valerie Robinson, DO. Polycystic Ovarian Syndrome (PCOS) is a disorder that causes menstrual and ovulation irregularities, androgen excess, and infertility.
Polycystic ovarian syndrome PCO
Screening for Diabetes in Pregnancy 1. Gestational Diabetes Mellitus Screening GDM, gestational diabetes mellitus. Handelsman YH, et al. Endocr Pract.
Biomarkers of ovarian cancer and cysts Reproductive Block 1 Lecture By: Reem Sallam, MD, MSc, PhD.
Source: Site Name and Year IHS Diabetes Audit Diabetes Health Status Report ______Site Name_________ Health Outcomes and Care Given to Patients with Diabetes.
Obesity, O&G and Risk Diana Hamilton-Fairley Consultant Obstetrician and Gynaecologist Guys and St. Thomas’ NHS Foundation Trust.
HDR Women’s Health 11 th April 2012 By Dr Mahya Mirfattahi GP ST3 POLYCYSTIC OVARY SYNDROME A SUMMARY OF RCOG GREEN-TOP GUIDELINE.
Polycystic Ovary Syndrome Melissa McCarthy June 1, 2010.
Polycystic Ovary Syndrome
Epidemiology of Diabetes Mellitus by Santi Martini Departemen of Epidemiology Faculty of Public Health University of Airlangga.
Cardiovascular Health and Risk Reduction in Children and Adolescents
PRE-EXISTING DIABETES AND PREGNANCY 2003 Clinical Practice Guidelines for the Prevention and Management of Diabetes in Canada.
OBesity Project Pregnancy.
Leveraging Weight Loss in the Treatment of Type 2 Diabetes Part 1 of 4.
POLYCYSTIC OVARY SYNDROME A COMMON FEMALE ENDOCRINE DISEASE SBI4U-01 Mr. Gajewski Bashour Yazji Jason Antrobus Narayan Wagle.
DR.ABHISHEK SINGH PARIHAR M.S (Obs & Gyne) ; FELLOW REPRODUCTIVE MEDICINE CONSULTANT : LIFECARE IVF CENTRE, NEW DELHI ABALONE CLINIC, NOIDA ETERNA IVF.
The Effects of Inositol on Women with Polycystic Ovary Syndrome(PCOS)
GDM-DEFINITION Gestational Diabetes Mellitus (GDM) is defined as ‘carbohydrate intolerance with recognition or onset during pregnancy’, irrespective of.
Diabetes National Diabetes Control Programme
Type 2 Diabetes – A Global Epidemic Arya M Sharma, MD, FRCP(C) Professor of Medicine Research Chair for Obesity Research & Management University of Alberta.
The Obesity/Diabetes Epidemic: Adiposopathy & ‘Obesity’- The New Disease! Weight Management in Obesity and DM: Emphasis on New Medical Therapies Stan Schwartz.
Pathogenesis (etiology?) Hypersecretion of adrenal androgens? Hypersecretion of ovarian androgens? A genetic disorder with an autosomal dominant mode.
A Diabetes Outcome Progression Trial
END Obesity Dr Gul Bano © S Nussey. What is obesity?
Insulin Resistance Progression to Diabetes. Hypertension: BP >140/90 Dyslipidemia: ◦TG >150 mg/dL (1.7 mmol.L) ◦HDL-C
Diagnosis of PCOS: 3998 Chinese cases NIH, Rotterdam criteria or AES ? NIH, Rotterdam criteria or AES ? Zi-Jiang Chen M.D., Ph.D Center for Reproductive.
PCOS & EXERCISE Bob Tygenhof, MA, CPT Director, Center for Active Lifestyle Medicine Integrative Medical Group of Irvine.
Diabetes Mellitus 101 for Cardiologists (and Alike): 2015
Pre-Gestational Diabetes: A Public Health Growth Industry Evan Klass, MD, FACP Associate Dean, Statewide Initiatives Director, Project ECHO-Nevada.
Diabetes Mellitus Introduction to Diabetes Epidemiology.
Laboratory Testing For Cardiovascular Risk
Polycystic Ovarian Syndrome Lindsay White. Polycystic Ovarian Syndrome (PCOS) is the most common cause of female infertility.
Evan Klass, MD, FACP Associate Dean, Statewide Initiatives Director, Project ECHO-Nevada Pre-Gestational Diabetes: A Public Health Growth Industry.
DR.GARIMA TYAGI Senior Consultant Obstetrician,Gynaecologist Infertility consultant & Laparoscopic Surgeon SHREE NARAYAN HOSPITAL, INDIRAPURAM,GHAZIABAD.
Bariatric Surgery for T2DM The STAMPEDE Trial. A.R. BMI 36.5 T2DM diagnosed age 24 On Metformin, glyburide  insulin Parents with T2DM, father on dialysis.
How Does Body Maintain Normal Blood Sugar? a Insulin Resistance and Its Consequences Sidika E. Karakas, M.D Professor and Chief Division of Endocrinology,
PCOS : Long Term Sequelae BY Mohammad Emam Prof. OB& GYN Mansoura Faculty of Medicine Mansoura Integrated Fertility Center EGYPT 2009.
Prevention Diabetes.
Diabetes Journal Club Carina Signori Endocrinology Fellow
Screening for Diabetes in Pregnancy
Orquidia Torres, MD Division of Adolescent and Young Adult Medicine
Division of Endocrinology, Diabetes and Metabolism
Diabetes Health Status Report
Screening and Monitoring
Repeat fasting lipid profile to confirm in 1-2 weeks
Screening for Diabetes in Pregnancy
Exercise and adult women’s health
Section overview: Cardiometabolic risk reduction
Cardiovascular Disease in Women Module III: Risk Assessment Tool
Prepared by :Dr. Latifa Mari’e
Presentation transcript:

Prevention & Management of PCOS Rashmi Kudesia, M.D. M.Sc. Icahn School of Medicine at Mount Sinai November 18, 2015

Objectives To highlight the dilemmas in PCOS management in the primary care setting To address barriers to comprehensive PCOS care for the female through the lifecourse

PCOS Lifecourse Birth Infancy & Childhood Adolescence Reproductive years Pregnancy Menopause & Beyond

Management of PCOS Most important goals – Avoiding over- and under-diagnosis – Counseling – Prioritize specific aspects affecting health and quality of life for each individual – Optimize fertility and pregnancy (prevention) – Minimize cardiometabolic sequelae

Diagnosis Dilemma 1: What are the best diagnostic criteria? – NIH – Rotterdam – Androgen Excess

Diagnosis – Dilemma 1 Common Pitfalls – Not adhering to strict criteria Gestalt impressions Applying sonographic criteria – Failure to recognize lean PCOS women – Failure to recognize racial & ethnic variations in phenotype and risk profile

Diagnosis Dilemma 2: What is the best approach to the child or adolescent with suspected PCOS? Pubertal symptoms overlap with PCOS criteria – Irregular menstruation – Acne – Weight gain

Diagnosis – Dilemma 2 Common Pitfalls: – Labeling an adolescent too early – And yet: failure to identify a child who has multiple risk factors – In a girl with suspected PCOS, failure to identify risk and provide counseling regarding: How the diagnosis might be confirmed Broad strokes of what diagnosis would mean Allay concerns and provide reassurance

Diagnosis – Dilemma 2 Routine fertility counseling for adolescents Teens with PCOS have greater fertility concerns than peers without PCOS

Counseling Dilemma 3: What are the most salient points in patient counseling once the diagnosis is established? The quality of PCOS care provided is largely determined by the quality of patient counseling

Counseling Common Pitfalls: – Only addressing patient’s acute concerns – Failure to counter misinformation from non- medical sources – Failure to explain which medications address which aspects of PCOS management

Lifelong Management Dilemma 4: In the era of personalized medicine, how best can one individualize PCOS care? OR, how can one take a patient-centered approach to the care of PCOS women?

Lifelong Management PCOSQ Questionnaire* helps identify which domains are most affecting current QOL – Emotions – Body hair – Weight – Infertility – Menstrual problems *Cronin et al JCEM 1998

Lifelong Management Consensus Guidelines from Endocrine Society (2010): – All PCOS women be assessed for CVD risk – BP, waist circumference & BMI at every visit – Complete lipid profile (target LDL) Reassess every 2 years or sooner if weight gain – 2h 75g OGTT in women with BMI>30 or in lean women with age>40, h/o GDM, FH of T2DM Reassess every 2 years or sooner if new risk factors A1c has promise – Assessment for depression, anxiety, QOL

Lifelong Management Common Pitfalls: – Failure to recognize shifting priorities – Discomfort with lifestyle counseling – Time limitations – Failure to emphasize or provide multi-disciplinary care with a team-based approach: Nutrition Exercise Bariatric surgery Endocrinology & cardiology

Lifelong Management Common Pitfalls: – Over-reliance on metformin

Lifelong Management Potential roles of metformin: – A meta-analysis of 31 trials concluded that metformin increases insulin sensitivity up to 20%, decreases weight and BMI by 3–5%, decreases fasting glucose by about 5%, and increases HDL-cholesterol and decreases triglycerides by approximately 10% in patients Weight loss enhances the effects of metformin Appears to decrease levels of C-reactive protein (low level chronic inflammation) May improve vascular endothelial function and coronary flow rate

Lifelong Management Common Pitfalls: – Over-reliance on metformin – Specific Indications for its usage: Prevent or slow progression to type 2 DM and long- term risks for cardiovascular disease) Women with IGT or DM, those with evidence of severe insulin resistance (acanthosis nigricans) and women having features of metabolic syndrome (central obesity, HTN, dyslipidemia) – Does not replace lifestyle modifications!

Lifelong Management Dilemma 5: How best to optimize fertility and pregnancy? Is there potential for prevention in the next generation?

Lifelong Management Common Pitfalls: – Failure to optimize health prior to conception Requires a detailed plan – Failure to select the most effective fertility treatment Clomiphene more effective (22.5%) than metformin monotherapy (7.2%) for live birth (Legro et al, NEJM 2007) PPCOS II demonstrated a rate ratio for live birth 1.44 [95% CI 1.1,1.9] with letrozole rather than clomiphene (Legro et al, NEJM 2014) Avoiding gonadotropins in non-IVF settings

Lifelong Management Common Pitfalls: – Failure to provide preemptive counseling regarding the elevated risks to PCOS women: Excessive pregnancy weight gain Gestational diabetes Gestational hypertension/preeclampsia Preterm labor Increased C-section rate Abnormal birthweight and impact on ultimate cardiometabolic health of their child

Lifelong Management Dilemma 6: How best to mitigate cardiometabolic sequelae for the woman with PCOS? What do we know about the risk?

Lifelong Management The impact of PCOS by time of menopausal transition is still poorly understood, however: *Kudesia et al Semin Repro Med 2014

Lifelong Management Thus, the overarching goals could be: – Stave off development of cardiometabolic co- morbidities in middle age – Emphasize lifestyle modification – Prevent or treat obesity – Such that, PCOS women enter post-menopause at similar risks to non-PCOS women

Conclusions The comprehensive management of PCOS requires: – A patient-centered approach – Significant time dedicated to thorough education and counseling – A network of referrals and local resources – Remaining up-to-date on newest advances in the literature – Improvement in health of the PCOS woman in pregnancy could help “prevent” disease in the next generation